1. Introduction {#sec1}
===============

Myxomas are a rare benign myxoid neoplasm of mesenchymal origin. They are a heterogeneous group of soft tissue neoplasms with a variable degree of invasiveness, ranging from benign to highly aggressive forms \[[@B1]\]. Although benign, they are known to be locally infiltrative in nature with a tendency to recur if not excised with margins \[[@B2]\]. Myxomas of head and neck region are rare tumours with the larynx being a less commonly affected site. Clinical presentation of laryngeal myxomas is very much similar to common benign mucosal fold disorders like laryngeal polyp or cyst. Clinically, laryngeal myxomas are indistinguishable from a laryngeal polyp. They are diagnosed on histology supplemented with immunohistochemistry.

2. Case Report {#sec2}
==============

A 53-year-old male presented with hoarseness of 12-year duration. He gave no history of breathing or swallowing difficulty. On enquiring further, he had complaints related to gastric acid reflux. He was a smoker but had quit smoking 6 months back. He is a politician with a history of voice abuse. On flexible fibreoptic evaluation, there was a 0.5 cm polypoidal, cystic mass pedicled on the medial free edge of the middle 1/3 of the right true vocal fold. There was no abnormality of vocal fold mobility. Rest of the ENT examination was normal.

Based on a history of long-standing hoarseness, voice abuse, and presence of a solitary polypoidal lesion over the true vocal fold, a preoperative diagnosis of a laryngeal polyp was made. No preoperative radiology was taken due to the unambiguous nature of the clinical findings. The patient was taken up for microlaryngeal surgery (MLS), and the lesion was excised with cold instruments. Postoperative period was uneventful with patient reporting near-normal voice during first follow-up after one week. Surprisingly, the postoperative histology showed features consistent with laryngeal myxoma.

On histological examination, our case showed a polypoidal tumour lined by hyperplastic stratified squamous epithelium ([Figure 1(a)](#fig1){ref-type="fig"}). A subepithelial unencapsulated lesion was noted. The latter was paucicellular formed by small, bland, spindle to stellate cells having indistinct cytoplasmic margins and hyperchromatic nuclei ([Figure 1(b)](#fig1){ref-type="fig"}). No significant atypia or mitotic activity or any necrosis was noted ([Figure 1(c)](#fig1){ref-type="fig"}). These cells were embedded within an abundant myxoid matrix. Immunohistochemically (IHC), the cells were negative for CD34, smooth muscle actin (SMA), and S100 (Figures [1(d)](#fig1){ref-type="fig"}--[1(f)](#fig1){ref-type="fig"}). Thus, a final diagnosis of laryngeal myxoma was rendered. The absence of stromal vasculature, hemorrhage, hemosiderin-laden macrophages, and hyalinization of basement membrane helped to differentiate it from a vocal fold polyp \[[@B3]\].

3. Discussion {#sec3}
=============

We did a comprehensive review of all the anecdotal cases of laryngeal myxoma reported in the literature so far which is summarized in [Table 1](#tab1){ref-type="table"} \[[@B3]--[@B20]\] after searching across PubMed, Google Scholar, Scopus, and Web of Science using the terms "Myxoma" and "laryngeal." All articles reporting laryngeal myxoma specifying tumour location and histological feature were included.

Larynx as a site for head and neck myxoma is extremely rare. Our comprehensive literature search revealed 19 cases of laryngeal myxoma till date ([Table 1](#tab1){ref-type="table"}). Male preponderance (M : F of 5 : 1) with a history of smoking is seen in a majority of cases reported. Our case also had both of these characteristics. Mean age at presentation was 52.16 years (range 36 to 77 years). Hoarseness was the most common presenting symptom signifying a predilection for the glottis, as seen in our case also. Dysphagia was reported in the studies by Baruah et al. and Chen et al. due to the involvement of the epiglottis \[[@B15], [@B20]\]. All authors documented the presence of a submucosal polypoidal mass ranging in size from 0.4 cm to 6.5 cm. Microlaryngeal surgery and excision by cold instruments was the preferred approach with one reported recurrence which responded to subtotal excision \[[@B4]\]. Tracheostomy was required preoperatively in two glottic myxomas due to airway compromise which was sorted after complete excision \[[@B5], [@B16]\]. Sena et al. utilized a transcervical route in his case where the primary one was located in the aryepiglottic fold \[[@B19]\].

Although we did not find any systemic association, at least three studies have revealed an association with Reinke\'s edema \[[@B3], [@B11], [@B16]\]. Possibility of Reinke\'s edema being a precursor lesion or sharing the same etiopathogenesis with myxoma needs to be studied in detail.

Demographically, laryngeal myxomas differ from other head and neck myxomas. A comprehensive review on head and neck myxoma by Andrews et al. \[[@B2]\] shows a female preponderance, with age group 18--67 years being affected. This study also quoted involvement of the paediatric age group. Laryngeal myxoma, on the contrary, seems to be a disease of males in the 5th--6th decade with a history of smoking.

Various theories for its etiopathogenesis have been put forth. Due to the abundance of mucinous matrix and glycosaminoglycans, fibroblast immaturity has been cited as a factor \[[@B21]\]. Another theory traces its origin to odontogenic primordial mesenchyme \[[@B3]\]. The latter probably explains the most common location for a myxoma in head and neck, that is, maxilla. Immature fibroblasts could be responsible for the occurrence in the larynx and also the association seen with Reinke\'s edema. Myxomas have been reported in mucopolysaccharidosis, Carney complex, and Mazabraud syndrome \[[@B3]\]. Mazabraud syndrome belongs to the spectrum of fibrous dysplasias where intramuscular myxomas have been described \[[@B22]\]. Carney complex is an autosomal dominant disorder characterized by cardiac myxomas, cutaneous hyperpigmentation, and multiple endocrinopathies in the form of raised ACTH and growth hormone. PRKAR1 alpha is the tumour suppressor gene implicated in this syndrome.

Histopathology forms the mainstay for diagnosing this entity. The usual clinical appearance is that of a benign vocal fold lesion like an intracordal cyst, polyp, or a nodule. It is the presence of myxoid stroma and abundance of stellate cells and spindle cells that help in clinching the diagnosis. There is no general consensus regarding myxoma-specific immunohistochemistry markers. All studies ([Table 1](#tab1){ref-type="table"}) have reported submucosal involvement, a predominance of stellate cells and spindle cells against the background of a mucinous matrix. Immunohistochemistry markers were available in three studies with no consensus regarding the significance of positivity of markers like CD34, SMA, S100, desmin, and Ki-67.

Head and neck myxomas are known for locally infiltrative nature and tendency to recur if not excised radically \[[@B2]\]. However, literature review suggested that microlaryngeal surgery performed from the point of view of a vocal fold polyp or cyst will generally suffice as it is evident by only one recurrence reported so far and long disease free intervals in other patients.

4. Conclusion {#sec4}
=============

Laryngeal myxomas should definitely be kept in the list of differential diagnosis when dealing with a benign looking vocal fold lesion. Patients need to be kept on close follow-up if excision has been suboptimal due to the absence of capsule and locally infiltrative nature.
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![Histopathology. (a--c) A polypoidal lesion lined by hyperplastic stratified squamous epithelium. Subepithelium shows a paucicellular mesenchymal tumour comprising small, bland, spindle, or stellate-shaped cells with small and hyperchromatic nuclei and inconspicuous cytoplasm dispersed in an abundant myxoid stroma. Cellular pleomorphism, mitotic figures, and necrosis are absent. (e--f) Results of immunohistochemistry with CD34, SMA, and S-100. The tumour cells are immunonegative for CD34, smooth muscle actin (SMA), and S100 ((a) HE 40x, (b) HE 100x, (c) HE 200x, (d) CD34 200x, (e) SMA 200x, and (f) S100 200x).](CRIOT2018-6868737.001){#fig1}

###### 

Systematic review of all cases of laryngeal myxoma.

  Author (year)                         Number of cases                   Age/sex   Presentation                              Addiction           Association        Site                          Size                     Approach         Follow-up        Histology                                                                   Need for tracheostomy
  ------------------------------------- --------------------------------- --------- ----------------------------------------- ------------------- ------------------ ----------------------------- ------------------------ ---------------- ---------------- --------------------------------------------------------------------------- -----------------------
  Tang et al. (2015) \[[@B4]\]          1                                 ND        Dysphonia                                 ND                  ---                Glottis                       ND                       Two approaches   ?Recurrence                                                                                  ---
  Ritchie et al. (2015) \[[@B3]\]       1                                 77/M      Hoarseness 6 months                       Smoker              Reinke\'s edema    Glottis                       \<1 cm                   MLS              3 months, NED    Stellate cell, spindle cell, and mucinous matrix. CD 34−, S100+, and SMA+   ---
  Singh et al. (2014) \[[@B5]\]         1                                 65/M      Hoarseness 4 months and dyspnoea 1 week   ND                  ---                Glottis                       17 × 12 mm               MLS              8 months, NED    -do-                                                                        Tracheostomy
  No IHC                                                                                                                                                                                                                                                                                                                                  
  Shah et al. (2014) \[[@B6]\]          1                                 50/M      Hoarseness 2 months                       ND                  ---                Glottis                       ---                      MLS              No f/u           -do-                                                                        ---
  No IHC                                                                                                                                                                                                                                                                                                                                  
  Garca et al. (2013) \[[@B7]\]         1                                 61/M      Hoarseness 3 months                       Smoker              ---                Glottis                       0.5 × 0.5 cm             MLS              No f/u           -do-                                                                        ---
  CD 34−, S100−, desmin−, and SMA−                                                                                                                                                                                                                                                                                                        
  Kanlıada et al. (2012) \[[@B8]\]      1                                 42/f      Hoarseness 3 months                       ---                 ---                Glottis                       4 mm                     MLS              12 months, NED   -do-                                                                        ---
  No IHC                                                                                                                                                                                                                                                                                                                                  
  Nakamura et al. (2008) \[[@B9]\]      1                                 74/f      Hoarseness                                Alcohol             ---                Glottis                       4 mm                     MLS              NED              -do-                                                                        ---
  No IHC                                                                                                                                                                                                                                                                                                                                  
  Song et al. (2008) \[[@B10]\]         1                                 36/M      Hoarseness 2 months                       ---                 ---                Glottis                       7 mm × 5 mm              MLS              4 months, NED    -do-                                                                        ---
  No IHC                                                                                                                                                                                                                                                                                                                                  
  Ali et al. (2008) \[[@B11]\]          1                                 48/F      Hoarseness childhood                      Smoker              Reinke\'s edema    Glottis                       ---                      MLS              ---              -do-                                                                        ---
  CD34+, S100−, and SMA−,Ki-67+                                                                                                                                                                                                                                                                                                           
  Leu et al. (2007) \[[@B12]\]          1                                 53/m      Hoarseness 2 years                        ---                 ---                Glottis                       5 mm                     MLS              ---              -do-                                                                        ---
  No IHC                                                                                                                                                                                                                                                                                                                                  
  Kim et al. (2007) \[[@B13]\]          2                                 62/m      Hoarseness 5 years                        Smoker              ---                Glottis                       1.5 × 0.8 × 0.4 cm       MLS              8 years, NED     -do-                                                                        ---
  No IHC                                                                                                                                                                                                                                                                                                                                  
  52/M                                  Hoarseness and dyspnoea 3 weeks   Smoker    ---                                       Glottis             2 × 0.4 × 0.4 cm   MLS                           3 years, 6 months, NED   -do-             ---                                                                                          
  NED                                                                                                                                                                                                                                                                                                                                     
  Idrees et al. (2005) \[[@B14]\]       1                                 46/M      ---                                       Smoker              ---                Glottis                       8 mm                     MLS              ---              -do-                                                                        ---
  No IHC                                                                                                                                                                                                                                                                                                                                  
  Baruah et al. (2001) \[[@B15]\]       1                                 57/M      Hoarseness                                ---                 ---                AEF/epiglottis                6.5 × 5.0 × 1 cm         MLS              ND               -do-                                                                        ---
  No IHC                                                                                                                                                                                                                                                                                                                                  
  Kim et al. (1997) \[[@B16]\]          1                                 62/M      Dyspnoea 3 days                           Smoker, alcoholic   Reinke\'s edema    Glottis, obstructing airway   2.5 × 2.5 × 1.5 cm       MLS              ---              -do-                                                                        Tracheostomy
  No IHC                                                                                                                                                                                                                                                                                                                                  
  Tsunoda et al. (1997) \[[@B17]\]      1                                 57/m      Hoarseness                                Alcoholic           ---                Glottis                       7 × 7 × 7 mm             MLS              NED              No IHC                                                                      ---
  Hadley et al. (1994) \[[@B18]\]       1                                 64/M      Hoarseness 4 years                        Alcoholic, smoker   ---                Glottis                       1 × 0.6 × 0.2 cm         MLS              18 months, NED   No IHC                                                                      ---
  Sena et al. (1991) \[[@B19]\]         1                                 70/M      Hoarseness                                Alcoholic, smoker   ---                AEF                           0.5 × 0.5 × 2.5 cm       Transcervical    12 months, NED   No IHC                                                                      ---
  Chen and Ballecer (1986) \[[@B20]\]   1                                 37/M      Dysphonia and dysphagia                   ---                 ---                Epiglottis                    5.6 × 4.3 × 2.4 cm       MLS              12 months, NED   No IHC                                                                      ---
  Present study (2016)                  1                                 53/M      Hoarseness 12 years                       Smoker              ---                Glottis                       0.5 cm                   MLS              4 months, NED    Immunonegative for CD34, SMA, and S100                                      ---
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